Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 4/20 | 0.59 |
| ▸ | CA12 | O43570 | 8/20 | 0.59 |
| ▸ | CA9 | Q16790 | 8/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.59 |
| ▸ | CA1 | P00915 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | GLA | P06280 | 4/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | CASP1 | P29466 | 2/20 | 0.59 |
| ▸ | CASP7 | P55210 | 2/20 | 0.59 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 4/20 | 0.54 |
| ▸ | CA5A | P35218 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30417141 | 1.00 | PGR (0.59) | PGRCA12CA9KDM4ECA1 | |
| SCHEMBL1094181 | 0.85 | PGR (0.73) | PGRCA12CA9KDM4ECA1 | |
| SCHEMBL15842518 | 0.78 | CA9 (0.59) | PGRCA12CA9KDM4ECA1 | |
| SCHEMBL28918550 | 0.77 | PGR (0.63) | PGRCA12CA9KDM4ECA1 | |
| SCHEMBL5539713 | 0.76 | CA12 (0.61) | CA12CA9KDM4ECA1ALDH1A1 | |
| SCHEMBL15842877 | 0.75 | POLB (0.49) | PGRCA12CA9KDM4ECA1 | |
| SCHEMBL5040810 | 0.74 | CA12 (0.59) | CA12CA9KDM4ECA1ALDH1A1 | |
| SCHEMBL11033273 | 0.74 | CA12 (0.59) | CA12CA9KDM4ECA1ALDH1A1 | |
| SCHEMBL31331748 | 0.74 | CA12 (0.59) | CA12CA9KDM4ECA1ALDH1A1 | |
| SCHEMBL7919707 | 0.74 | CA12 (0.59) | CA12CA9KDM4ECA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| US-20250290137-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-09-18 | — | — | US | disclosed |
| US-12351871-B2 | Substituted coumarin dyes and uses as fluorescent labels | ILLUMINA CAMBRIDGE LIMITED (GB) | 2025-07-08 | — | — | US | disclosed |
| US-20240271209-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-08-15 | — | — | US | disclosed |
| US-20240213536-A1 | Lithium Secondary Battery | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-20240213536-A1 | Lithium Secondary Battery | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-11981964-B2 | Substituted coumarin dyes and uses as fluorescent labels | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-05-14 | — | — | US | disclosed |
| WO-2023219474-A1 | NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | 주식회사 엘지에너지솔루션 | 2023-11-16 | — | — | WO | disclosed |
| EP-4188921-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | Illumina Cambridge Limited (GB) | 2023-06-07 | — | — | EP | disclosed |
| CN-115867544-A | Substituted coumarin dyes and their use as fluorescent labels | 伊鲁米纳剑桥有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20090005580-A1 | Compounds, compositions and methods | CYTOKINETICS, INC. | 2009-01-01 | — | — | US | disclosed |
| EP-1511734-A4 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS INC (US) | 2006-05-10 | — | — | EP | disclosed |
| US-20060020008-A1 | Treating cell proliferation disorder, anticancer agents | CYTOKINETICS, INC. | 2006-01-26 | — | — | US | disclosed |
| US-6924376-B2 | Compounds, compositions and methods | CYTOKINETICS, INC. (US) | 2005-08-02 | — | — | US | disclosed |
| EP-1511734-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2005-03-09 | — | — | EP | disclosed |
| WO-2003088903-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2003-10-30 | — | — | WO | disclosed |
| EP-0185319-B1 | FLUORO COUMARINS AS ANTILYMPHOEDEMA AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1989-09-06 | — | — | EP | disclosed |
| US-4749798-A | ANTIINFLAMMATORY, ANTISWELLING | BOEHRINGER BIOCHEMIA ROBIN SPA (IT) | 1988-06-07 | — | — | US | disclosed |
| EP-0185319-A2 | Fluoro coumarins as antilymphoedema agents | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1986-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11981964-B2 | Substituted coumarin dyes and uses as fluorescent labels | FBL, DUT, PHAX | PGR 1849/4885CA12 4179/4885CA9 3934/4885 |
| US-20060020008-A1 | Treating cell proliferation disorder, anticancer agents | MKI67, PCNA, TK1 | PGR 1555/4885CA12 3242/4885CA9 4129/4885 |
| US-20090005580-A1 | Compounds, compositions and methods | ALPP, PCNA, MKI67 | PGR 714/4885CA12 1601/4885CA9 2719/4885 |
| US-20250290137-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | FBL, DUT, PHAX | PGR 1849/4885CA12 4179/4885CA9 3934/4885 |
| US-20240271209-A1 | SUBSTITUTED COUMARIN DYES AND USES AS FLUORESCENT LABELS | FBL, DUT, PHAX | PGR 1849/4885CA12 4179/4885CA9 3934/4885 |
| US-12351871-B2 | Substituted coumarin dyes and uses as fluorescent labels | FBL, DUT, PHAX | PGR 1849/4885CA12 4179/4885CA9 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.